Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 263

1.

Global Determinants of Navigation Ability.

Coutrot A, Silva R, Manley E, de Cothi W, Sami S, Bohbot VD, Wiener JM, Hölscher C, Dalton RC, Hornberger M, Spiers HJ.

Curr Biol. 2018 Aug 7. pii: S0960-9822(18)30771-1. doi: 10.1016/j.cub.2018.06.009. [Epub ahead of print]

PMID:
30100340
2.

Living Donor Post-Nephrectomy Kidney Function and Recipient Graft Loss: A Dose-Response Relationship.

Holscher CM, Ishaque T, Garonzik Wang JM, Haugen CE, DiBrito SR, Jackson K, Muzaale AD, Massie AB, Al Ammary F, Ottman SE, Henderson ML, Segev DL.

Am J Transplant. 2018 Aug 7. doi: 10.1111/ajt.15061. [Epub ahead of print]

PMID:
30086198
3.

Complications, length of stay, and cost of cholecystectomy in kidney transplant recipients.

DiBrito SR, Haugen CE, Holscher CM, Olorundare IO, Alimi Y, Segev DL, Garonzik-Wang J.

Am J Surg. 2018 Jul 19. pii: S0002-9610(18)30026-6. doi: 10.1016/j.amjsurg.2018.07.023. [Epub ahead of print]

PMID:
30064724
4.

Temporal Changes in the Composition of a Large Multicenter Kidney Exchange Clearinghouse: Do the Hard-to-Match Accumulate?

Holscher CM, Jackson K, Thomas AG, Haugen CE, DiBrito SR, Covarrubias K, Gentry SE, Ronin M, Waterman AD, Massie AB, Garonzik Wang J, Segev DL.

Am J Transplant. 2018 Jul 31. doi: 10.1111/ajt.15046. [Epub ahead of print]

PMID:
30063811
5.

Neuroprotective effects of the novel GLP-1 long acting analogue semaglutide in the MPTP Parkinson's disease mouse model.

Zhang L, Zhang L, Li L, Hölscher C.

Neuropeptides. 2018 Jul 11. pii: S0143-4179(18)30068-4. doi: 10.1016/j.npep.2018.07.003. [Epub ahead of print]

PMID:
30017231
6.

Prospective Validation of Prediction Model for Kidney Discard.

Zhou S, Massie AB, Holscher CM, Waldram MM, Ishaque T, Thomas AG, Segev DL.

Transplantation. 2018 Jul 13. doi: 10.1097/TP.0000000000002362. [Epub ahead of print]

PMID:
30015701
7.

Landscape of Living Multiorgan Donation in the United States: A Registry-Based Cohort Study.

Henderson ML, DiBrito SR, Thomas AG, Holscher CM, Shaffer AA, Bowring MG, Purnell TS, Massie AB, Garonzik-Wang JM, Waldram MM, Lentine KL, Segev DL.

Transplantation. 2018 Jul;102(7):1148-1155. doi: 10.1097/TP.0000000000002082.

PMID:
29952925
8.

Are Alzheimer's disease and other neurodegenerative disorders caused by impaired signalling of insulin and other hormones?

Hölscher C, De Felice FG, Greig NH, Ferreira ST.

Neuropharmacology. 2018 Jul 1;136(Pt B):159. doi: 10.1016/j.neuropharm.2018.05.021. Epub 2018 May 18. No abstract available.

PMID:
29782874
9.

Differing Outcome of Experimental Autoimmune Encephalitis in Macrophage/Neutrophil- and T Cell-Specific gp130-Deficient Mice.

Holz K, Prinz M, Brendecke SM, Hölscher A, Deng F, Mitrücker HW, Rose-John S, Hölscher C.

Front Immunol. 2018 May 2;9:836. doi: 10.3389/fimmu.2018.00836. eCollection 2018.

10.

Outcomes Following Colorectal Resection in Kidney Transplant Recipients.

DiBrito SR, Alimi Y, Olorundare IO, Holscher CM, Haugen CE, Segev DL, Garonzik-Wang J.

J Gastrointest Surg. 2018 May 7. doi: 10.1007/s11605-018-3801-2. [Epub ahead of print]

PMID:
29736667
11.

The increased protection and pathology in Mycobacterium tuberculosis-infected IL-27R-alpha-deficient mice is supported by IL-17A and is associated with the IL-17A-induced expansion of multifunctional T cells.

Erdmann H, Behrends J, Ritter K, Hölscher A, Volz J, Rosenkrands I, Hölscher C.

Mucosal Immunol. 2018 Jul;11(4):1168-1180. doi: 10.1038/s41385-018-0026-3. Epub 2018 May 4.

PMID:
29728641
12.

Correlation Between Kidney Transplant Outcome Metrics and Waitlist Metrics.

Zhou S, Holscher CM, Massie AB, Segev DL, Nicholas LH.

Transplantation. 2018 Aug;102(8):e362-e363. doi: 10.1097/TP.0000000000002254. No abstract available.

PMID:
29688995
13.

How Should Social Media Be Used in Transplantation? A Survey of The American Society of Transplant Surgeons.

Henderson ML, Adler JT, Van Pilsum Rasmussen SE, Thomas AG, Herron PD, Waldram MM, Ruck JM, Purnell TS, DiBrito SR, Holscher CM, Haugen CE, Alimi Y, Konel JM, Eno AK, Garonzik Wang JM, Gordon EJ, Lentine KL, Schaffer RL, Cameron AM, Segev DL.

Transplantation. 2018 Apr 21. doi: 10.1097/TP.0000000000002243. [Epub ahead of print]

PMID:
29684002
14.

De Novo Fatty Acid Synthesis During Mycobacterial Infection Is a Prerequisite for the Function of Highly Proliferative T Cells, But Not for Dendritic Cells or Macrophages.

Stüve P, Minarrieta L, Erdmann H, Arnold-Schrauf C, Swallow M, Guderian M, Krull F, Hölscher A, Ghorbani P, Behrends J, Abraham WR, Hölscher C, Sparwasser TD, Berod L.

Front Immunol. 2018 Apr 5;9:495. doi: 10.3389/fimmu.2018.00495. eCollection 2018.

15.

The Modern Surgeon Scientist.

DiBrito SR, Holscher CM, Haugen CE, Leeds IL, Overton HN, Jackson KR, King EA, Haut ER.

Ann Surg. 2018 Apr 6. doi: 10.1097/SLA.0000000000002756. [Epub ahead of print] No abstract available.

PMID:
29629908
16.

Surgical approach, cost, and complications of appendectomy in kidney transplant recipients.

DiBrito SR, Olorundare IO, Holscher CM, Landazabal CS, Orandi BJ, Dagher NN, Segev DL, Garonzik-Wang J.

Clin Transplant. 2018 May;32(5):e13245. doi: 10.1111/ctr.13245. Epub 2018 Apr 17.

PMID:
29577448
17.

DA5-CH, a novel GLP-1/GIP dual agonist, effectively ameliorates the cognitive impairments and pathology in the APP/PS1 mouse model of Alzheimer's disease.

Cao Y, Hölscher C, Hu MM, Wang T, Zhao F, Bai Y, Zhang J, Wu MN, Qi JS.

Eur J Pharmacol. 2018 May 15;827:215-226. doi: 10.1016/j.ejphar.2018.03.024. Epub 2018 Mar 15.

PMID:
29551659
18.

Post-treatment with the GLP-1 analogue liraglutide alleviate chronic inflammation and mitochondrial stress induced by Status epilepticus.

Wang RF, Xue GF, Hölscher C, Tian MJ, Feng P, Zheng JY, Li DF.

Epilepsy Res. 2018 May;142:45-52. doi: 10.1016/j.eplepsyres.2018.03.009. Epub 2018 Mar 9.

PMID:
29549796
19.

A novel GLP-1/GIP/Gcg triagonist reduces cognitive deficits and pathology in the 3xTg mouse model of Alzheimer's disease.

Li T, Jiao JJ, Hölscher C, Wu MN, Zhang J, Tong JQ, Dong XF, Qu XS, Cao Y, Cai HY, Su Q, Qi JS.

Hippocampus. 2018 May;28(5):358-372. doi: 10.1002/hipo.22837. Epub 2018 Mar 5.

PMID:
29473979
20.

Two novel dual GLP-1/GIP receptor agonists are neuroprotective in the MPTP mouse model of Parkinson's disease.

Feng P, Zhang X, Li D, Ji C, Yuan Z, Wang R, Xue G, Li G, Hölscher C.

Neuropharmacology. 2018 May 1;133:385-394. doi: 10.1016/j.neuropharm.2018.02.012. Epub 2018 Feb 17.

PMID:
29462693
21.

Kidney exchange match rates in a large multicenter clearinghouse.

Holscher CM, Jackson K, Chow EKH, Thomas AG, Haugen CE, DiBrito SR, Purcell C, Ronin M, Waterman AD, Garonzik Wang J, Massie AB, Gentry SE, Segev DL.

Am J Transplant. 2018 Jun;18(6):1510-1517. doi: 10.1111/ajt.14689. Epub 2018 Mar 9.

PMID:
29437286
22.

The diabetes drug liraglutide reverses cognitive impairment in mice and attenuates insulin receptor and synaptic pathology in a non-human primate model of Alzheimer's disease.

Batista AF, Forny-Germano L, Clarke JR, Lyra E Silva NM, Brito-Moreira J, Boehnke SE, Winterborn A, Coe BC, Lablans A, Vital JF, Marques SA, Martinez AM, Gralle M, Holscher C, Klein WL, Houzel JC, Ferreira ST, Munoz DP, De Felice FG.

J Pathol. 2018 May;245(1):85-100. doi: 10.1002/path.5056. Epub 2018 Apr 2.

23.

GLP-1 receptor agonists show neuroprotective effects in animal models of diabetes.

Gault VA, Hölscher C.

Peptides. 2018 Feb;100:101-107. doi: 10.1016/j.peptides.2017.11.017.

PMID:
29412810
24.

Novel dual GLP-1/GIP receptor agonists show neuroprotective effects in Alzheimer's and Parkinson's disease models.

Hölscher C.

Neuropharmacology. 2018 Jul 1;136(Pt B):251-259. doi: 10.1016/j.neuropharm.2018.01.040. Epub 2018 Jan 31. Review.

PMID:
29402504
25.

Suppressor of Cytokine Signaling 3 in Macrophages Prevents Exacerbated Interleukin-6-Dependent Arginase-1 Activity and Early Permissiveness to Experimental Tuberculosis.

Schmok E, Abad Dar M, Behrends J, Erdmann H, Rückerl D, Endermann T, Heitmann L, Hessmann M, Yoshimura A, Rose-John S, Scheller J, Schaible UE, Ehlers S, Lang R, Hölscher C.

Front Immunol. 2017 Nov 10;8:1537. doi: 10.3389/fimmu.2017.01537. eCollection 2017.

26.

Expanding the Use of Organs From Hepatitis C-Viremic Donors: The Evidence Continues to Build.

Holscher CM, Durand CM, Desai NM.

Transplantation. 2018 Apr;102(4):546-547. doi: 10.1097/TP.0000000000002032. No abstract available.

PMID:
29176392
27.

Liraglutide restores chronic ER stress, autophagy impairments and apoptotic signalling in SH-SY5Y cells.

Panagaki T, Michael M, Hölscher C.

Sci Rep. 2017 Nov 23;7(1):16158. doi: 10.1038/s41598-017-16488-x.

28.

Turn down for what? Patient outcomes associated with declining increased infectious risk kidneys.

Bowring MG, Holscher CM, Zhou S, Massie AB, Garonzik-Wang J, Kucirka LM, Gentry SE, Segev DL.

Am J Transplant. 2018 Mar;18(3):617-624. doi: 10.1111/ajt.14577. Epub 2017 Dec 5.

PMID:
29116674
29.

Factors associated with perceived donation-related financial burden among living kidney donors.

Ruck JM, Holscher CM, Purnell TS, Massie AB, Henderson ML, Segev DL.

Am J Transplant. 2018 Mar;18(3):715-719. doi: 10.1111/ajt.14548. Epub 2017 Nov 21.

PMID:
29068176
30.

Neuroprotective effects of a triple GLP-1/GIP/glucagon receptor agonist in the APP/PS1 transgenic mouse model of Alzheimer's disease.

Tai J, Liu W, Li Y, Li L, Hölscher C.

Brain Res. 2018 Jan 1;1678:64-74. doi: 10.1016/j.brainres.2017.10.012. Epub 2017 Oct 16.

PMID:
29050859
31.

Persistent regional and racial disparities in nondirected living kidney donation.

Kumar K, Holscher CM, Luo X, Garonzik Wang J, Anjum S, King EA, Massie AB, Tonascia JM, Purnell TS, Segev DL.

Clin Transplant. 2017 Dec;31(12). doi: 10.1111/ctr.13135. Epub 2017 Nov 2.

PMID:
29032601
32.

Unplanned 30-day readmission in patients with diabetic foot wounds treated in a multidisciplinary setting.

Holscher CM, Hicks CW, Canner JK, Sherman RL, Malas MB, Black JH 3rd, Mathioudakis N, Abularrage CJ.

J Vasc Surg. 2018 Mar;67(3):876-886. doi: 10.1016/j.jvs.2017.07.131. Epub 2017 Oct 7.

PMID:
29017807
33.

Evaluation of a conceptual framework for predicting navigation performance in virtual reality.

Grübel J, Thrash T, Hölscher C, Schinazi VR.

PLoS One. 2017 Sep 15;12(9):e0184682. doi: 10.1371/journal.pone.0184682. eCollection 2017.

34.

Integrating microRNA and messenger RNA expression profiles in a rat model of deep vein thrombosis.

Jin QQ, Sun JH, Du QX, Lu XJ, Zhu XY, Fan HL, Hölscher C, Wang YY.

Int J Mol Med. 2017 Oct;40(4):1019-1028. doi: 10.3892/ijmm.2017.3105. Epub 2017 Aug 23.

35.

A novel GLP-1/GIP dual agonist is more effective than liraglutide in reducing inflammation and enhancing GDNF release in the MPTP mouse model of Parkinson's disease.

Yuan Z, Li D, Feng P, Xue G, Ji C, Li G, Hölscher C.

Eur J Pharmacol. 2017 Oct 5;812:82-90. doi: 10.1016/j.ejphar.2017.06.029. Epub 2017 Jun 27.

PMID:
28666800
36.

Therapeutic Potential of Baicalein in Alzheimer's Disease and Parkinson's Disease.

Li Y, Zhao J, Hölscher C.

CNS Drugs. 2017 Aug;31(8):639-652. doi: 10.1007/s40263-017-0451-y. Review.

PMID:
28634902
37.

Metabolomic Profiling of Bile Acids in Clinical and Experimental Samples of Alzheimer's Disease.

Pan X, Elliott CT, McGuinness B, Passmore P, Kehoe PG, Hölscher C, McClean PL, Graham SF, Green BD.

Metabolites. 2017 Jun 17;7(2). pii: E28. doi: 10.3390/metabo7020028.

38.

The National Landscape of Living Kidney Donor Follow-Up in the United States.

Henderson ML, Thomas AG, Shaffer A, Massie AB, Luo X, Holscher CM, Purnell TS, Lentine KL, Segev DL.

Am J Transplant. 2017 Dec;17(12):3131-3140. doi: 10.1111/ajt.14356. Epub 2017 Jun 30.

PMID:
28510355
39.

[GLP-1/GIP/Gcg receptor Triagonist improves the cognitive behaviors in triple-transgenic mice of Alzheimer's disease].

Jiao JJ, Hölscher C, Li T, Dong XF, Qu XS, Cao Y, Wu MN, Wang ZJ, Qi JS.

Sheng Li Xue Bao. 2017 Apr 25;69(2):135-145. Chinese.

40.

A novel dual GLP-1/GIP receptor agonist alleviates cognitive decline by re-sensitizing insulin signaling in the Alzheimer icv. STZ rat model.

Shi L, Zhang Z, Li L, Hölscher C.

Behav Brain Res. 2017 Jun 1;327:65-74. doi: 10.1016/j.bbr.2017.03.032. Epub 2017 Mar 23.

PMID:
28342971
41.

A novel GLP-1/GIP dual receptor agonist protects from 6-OHDA lesion in a rat model of Parkinson's disease.

Jalewa J, Sharma MK, Gengler S, Hölscher C.

Neuropharmacology. 2017 May 1;117:238-248. doi: 10.1016/j.neuropharm.2017.02.013. Epub 2017 Feb 20.

PMID:
28223210
42.

DNA Damage Signaling Instructs Polyploid Macrophage Fate in Granulomas.

Herrtwich L, Nanda I, Evangelou K, Nikolova T, Horn V, Sagar, Erny D, Stefanowski J, Rogell L, Klein C, Gharun K, Follo M, Seidl M, Kremer B, Münke N, Senges J, Fliegauf M, Aschman T, Pfeifer D, Sarrazin S, Sieweke MH, Wagner D, Dierks C, Haaf T, Ness T, Zaiss MM, Voll RE, Deshmukh SD, Prinz M, Goldmann T, Hölscher C, Hauser AE, Lopez-Contreras AJ, Grün D, Gorgoulis V, Diefenbach A, Henneke P, Triantafyllopoulou A.

Cell. 2016 Nov 17;167(5):1264-1280.e18. doi: 10.1016/j.cell.2016.09.054. Epub 2016 Oct 27.

43.

Therapeutic potential of flavonoids in spinal cord injury.

Zhang P, Hölscher C, Ma X.

Rev Neurosci. 2017 Jan 1;28(1):87-101. doi: 10.1515/revneuro-2016-0053. Review.

PMID:
28045676
44.

D-Ala2-GIP-glu-PAL is neuroprotective in a chronic Parkinson's disease mouse model and increases BNDF expression while reducing neuroinflammation and lipid peroxidation.

Li Y, Liu W, Li L, Hölscher C.

Eur J Pharmacol. 2017 Feb 15;797:162-172. doi: 10.1016/j.ejphar.2016.11.050. Epub 2016 Nov 29.

PMID:
27913104
45.

Lixisenatide attenuates the detrimental effects of amyloid β protein on spatial working memory and hippocampal neurons in rats.

Cai HY, Wang ZJ, Hölscher C, Yuan L, Zhang J, Sun P, Li J, Yang W, Wu MN, Qi JS.

Behav Brain Res. 2017 Feb 1;318:28-35. doi: 10.1016/j.bbr.2016.10.033. Epub 2016 Oct 21.

PMID:
27776993
46.

Levo-tetrahydropalmatine inhibits the acquisition of ketamine-induced conditioned place preference by regulating the expression of ERK and CREB phosphorylation in rats.

Du Y, Du L, Cao J, Hölscher C, Feng Y, Su H, Wang Y, Yun KM.

Behav Brain Res. 2017 Jan 15;317:367-373. doi: 10.1016/j.bbr.2016.10.001. Epub 2016 Oct 3.

PMID:
27713001
47.

A Novel Bioresorbable Device as a Controlled Release System for Protecting Cells from Oxidative Stress from Alzheimer's Disease.

Salles GN, Pereira FADS, Pacheco-Soares C, Marciano FR, Hölscher C, Webster TJ, Lobo AO.

Mol Neurobiol. 2017 Nov;54(9):6827-6838. doi: 10.1007/s12035-016-0200-0. Epub 2016 Oct 20.

PMID:
27766537
49.

Crowd behaviour during high-stress evacuations in an immersive virtual environment.

Moussaïd M, Kapadia M, Thrash T, Sumner RW, Gross M, Helbing D, Hölscher C.

J R Soc Interface. 2016 Sep;13(122). pii: 20160414. doi: 10.1098/rsif.2016.0414.

50.

Novel incretin analogues improve autophagy and protect from mitochondrial stress induced by rotenone in SH-SY5Y cells.

Jalewa J, Sharma MK, Hölscher C.

J Neurochem. 2016 Oct;139(1):55-67. doi: 10.1111/jnc.13736. Epub 2016 Aug 24.

Supplemental Content

Loading ...
Support Center